Erythème borrélien de la face [Borrelial erythema of the face]

Détails

ID Serval
serval:BIB_F0B794C6B2AB
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Titre
Erythème borrélien de la face [Borrelial erythema of the face]
Périodique
Annales de Dermatologie et de Vénéréologie
Auteur(s)
de Heller-Milev M., Peter O., Panizzon R.G., Laffitte E.
ISSN
0151-9638
Statut éditorial
Publié
Date de publication
2008
Peer-reviewed
Oui
Volume
135
Numéro
12
Pages
852-854
Langue
français
Notes
Publication types: Case Reports ; English Abstract ; Journal Article
Résumé
BACKGROUND: Borrelial infection is characterized by various skin manifestations that are usually classified into three main types: chronic migratory erythema, borrelial lymphocytoma and acrodermatitis chronica atrophicans. We report an unusual case of borrelial cutaneous infection presenting as a mediofacial erythema that cannot be included in any of these three categories. CASE REPORT: A 51-year-old woman presented with infiltrated erythema of the middle of the face extending to the neck and chin. Medical history and physical examination revealed no signs of rosaceae. Infection with Borrelia was suspected on skin biopsy examination, which showed an inflammatory dermal infiltrate containing numerous plasma cells. The diagnosis of B.afzelii infection was confirmed by serology and polymerase chain reaction on the skin biopsy, both of which were positive for B.afzelii. DISCUSSION: Borrelial erythema of the face may represent a special form of cutaneous borrelial infection, which must be considered in the differential diagnosis of facial erythema, especially in areas of endemic borreliosis.
Mots-clé
Anti-Bacterial Agents/administration & dosage, Anti-Bacterial Agents/therapeutic use, Biopsy, Borrelia burgdorferi Group/genetics, Borrelia burgdorferi Group/immunology, Diagnosis, Differential, Doxycycline/administration & dosage, Doxycycline/therapeutic use, Erythema Chronicum Migrans/diagnosis, Erythema Chronicum Migrans/drug therapy, Facial Dermatoses/diagnosis, Facial Dermatoses/drug therapy, Female, Follow-Up Studies, Humans, Immunoblotting, Middle Aged, Polymerase Chain Reaction, Skin/pathology, Time Factors, Treatment Outcome
Pubmed
Web of science
Création de la notice
04/01/2010 18:16
Dernière modification de la notice
03/03/2018 22:37
Données d'usage